Breakthrough omicron COVID-19 infections in patients receiving the REGEN-Cov antibody combination

Kidney Int. 2022 Apr;101(4):824-825. doi: 10.1016/j.kint.2022.01.016. Epub 2022 Feb 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neutralizing
  • COVID-19 Vaccines / adverse effects
  • COVID-19*
  • Drug Combinations
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neutralizing
  • COVID-19 Vaccines
  • Drug Combinations
  • casirivimab and imdevimab drug combination